Thyroid dysfunction and the state of the GH/IGF-1 system in adolescents with type 1 diabetes mellitus

Authors

DOI:

https://doi.org/10.15391/prrht.2023-8(1).06

Keywords:

adolescents, type 1 diabetes mellitus, growth hormone, insulin-like growth factor type 1, pituitary-thyroid system

Abstract

Purpose: to determine the relationship between the functional state of the pituitary-thyroid system and the growth hormone/insulin-like growth factor type 1 (GH/IGF-1) system in adolescents with type 1 diabetes mellitus (DM1) during puberty

Material & Methods: 165 children (85 girls (51,5%) and 80 boys (48,5%) aged 8 to 18 years old who have DM1 and are in the endocrinology department of the State Institution "Institute for Children and Adolescents Health Care at the National Academy of Medical Sciences of Ukraine" (SI "ICAHC NAMS"). The criterion for inclusion in the study was the duration of DM1 for more than one year (from 1 to 16 years). The level of thyrotropin (TSH), free fractions of thyroxin (fT4) and triiodothyronine (fT3), GH and IGF-1 was determined and the ratio (fT3/fT4 and TSH/fT4) was calculated. Study participants were divided into groups depending on the level of sexual development (T1-T4) at the time of the study, assessed by the Marshall & Tanner scale (Marshall & Tanner, 1969; Marshall & Tanner, 1970); functional state of the pituitary-thyroid system: (euthyroidism (TSH/fТ4 <0,19 c.u.), minimal thyroid insufficiency (0,19 c.u. ≤ TSH/fТ4 ≤0,29 c.u.), with subclinical hypothyroidism (TSH/fТ4 >0,29 c.u.) (Turchina et al., 2016).

Results: it was found that among adolescents with DM1, almost every child has signs of thyroid dysfunction. An increase in the fT3 level and the fT3/fT4 ratio were more often diagnosed. The frequency of increase in the level of TSH and the ratio of TSH/fT4 fluctuated widely and depended on the sexual development of the child. More often, signs of SGH were determined during early puberty (23,5%), which probably exceeded those in prepubertal (16%, Pφ<0,05), proper (8,9%, Pφ<0,05) and late puberty (6,1%, Pφ<0,05). These changes indicate the tension of the thyroid system at the beginning of puberty, which is the basis not only for an increase in the risk of thyroid pathology in this period of puberty, but also for violations of physical and sexual development.

Conclusions: almost a third of adolescents with DM1 had signs of thyroid insufficiency of varying degrees, which was most often determined during early puberty. The progression of thyroid insufficiency was accompanied by a decrease in the level of GH and IGF-1.

References

Biondi, B., Kahaly, G.J., & Robertson, R.P. (2019). Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders, Endocrine Reviews, 40(3), 789-824. https://doi.org/10.1210/er.2018-00163

Budrejko, O.A. (2011). Diabetes mellitus type 1 in children and adolescents: features of the course and possibilities of optimization of therapy [Abstract of the doctoral dissertation, State University “V.P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Sciences of Ukraine”]. Kyiv. https://bit.ly/3LII8bk

Cabello, G., & Wrutniak, C. (1989). Thyroid hormone and growth: Relationships with growth hormone effects and regulation. Reprod. Nutr. Dev., 29, 387-402. https://doi.org/10.1051/rnd:19890401

Fatourechi, A., Ardakani, H.M., Sayarifard, F., & Sheikh, M. (2017). Hypothyroidism among pediatric patients with type 1 diabetes mellitus, from patients’ characteristics to disease severity. Clin Pediatr Endocrinol. 26(2), 73-80. https://doi.org/10.1297/cpe.26.73

Feldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021). The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions. Mol. Cell. Endocrinol., 525, 111173. https://doi.org/10.1016/j.mce.2021.111173

Forhead, A.J., & Fowden, A.L. (2014). Thyroid Hormone Regulation of Metabolism. Physiol. Rev., 94(2), 355-382. https://doi.org/10.1152/physrev.00030.2013

Hellström, A., Ley, D., Hansen-Pupp, I., Hallberg, B., Löfqvist, C., van Marter, L., an Weissenbruch, M., Ramenghi, L.A., Beardsall, K., Dunger, D., Hård, A-L., & Smith, L.E.H. (2016). Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development. Acta Paediatr., 105(6), 576-586. https://doi.org/10.1111/apa.13350

Ipsa, E., Cruzat, V.F., Kagize, J.N., Yovich, J.L., & Keane, K.N. (2019). Growth Hormone and Insulin-Like Growth Factor Action in Reproductive Tissues. Front. Endocrinol., 10, 777. https://doi.org/10.3389/fendo.2019.00777

Kostenko, T.P. (2022). Frequency and nature of thyroid pathology in children and adolescents with type 1 diabetes mellitus and its influence on sexual development. Ukrainian Journal of Pediatric Endocrinology. 3-4(43-44), 21-26. https://doi.org/10.30978/UJPE2022-3-4-21

Laron, Z. (2003). Interactions between the thyroid hormones and the hormones of the growth hormone axis. Pediatr. Endocrinol. Rev., 1 Suppl 2, 244-9-discussion 250. PMID, 16444165. https://europepmc.org/article/med/16444165

Murray, P.G., & Clayton, P.E. (2013, April). Endocrine control of growth. American Journal of Medical Genetics Part C: Seminars in Medical Genetics., 163C, 76-85. https://doi.org/10.1002/j.1552-4876.2013.31357.x

Nambam, B., & Schatz, D. (2018). Growth hormone and insulin-like growth factor-I axis in type 1 diabetes. Growth Hormone & IGF Research, 38, 49-52. https://doi.org/10.1016/j.ghir.2017.12.005

Robson, H., Siebler, T., Shalet, S.M., & Williams, G.R. (2002). Interactions between, G.H., IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr. Res., 52, 137-147. https://doi.org/10.1203/00006450-200208000-00003

Sato, T., Suzuki, Y., Taketani, T., Ishiguro, K., Masuyama, T., Takata, I., Sano, M., Kawashima, H., Koizumi, S., & Nakajima, H. (1977). Enhanced Peripheral Conversion of Thyroxine to Triiodothyronine During hGH Therapy in GH Deficient Children. J. Clin. Endocrinol. Metab. 45(2), 324-329. https://doi.org/10.1210/jcem-45-2-324

Sellitti, D.F., & Suzuki, K. (2014). Intrinsic regulation of thyroid function by thyroglobulin. Thyroid, 24(4), 625-638. https://doi.org/10.1089/thy.2013.0344

Sellitti, D.F., & Suzuki, K. (2014). Intrinsic regulation of thyroid function by thyroglobulin. Thyroid, 24(4), 625-638. https://doi.org/10.1089/thy.2013.0344

Silva, J.R.V., Figueiredo, J.R., & van den Hurk, R. (2009). Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Theriogenology, 71(8), 1193-1208. https://doi.org/10.1016/j.theriogenology.2008.12.015

Sotnikova-Meleshkina, Z., Turchіna, S., Varodova, O., Havrylova, T., Kalmykova, Y., & Kalmykov, S. (2022). Characteristics of nutrition of boys with hypoandrogenia of various degrees. Problems of Endocrine Pathology, 79(3), 35-41. https://doi.org/10.21856/j-PEP.2022.3.05

Turchina, S.I. (2010). Changes of the thyroid status of adolescents with diffuse non-toxic goiter at the stages of puberty. Probl. endocr. Pathol., 4, 19-25. https://doi.org/10.21856/j-PEP.2010.4.03

Turchina, S.I., Nachetova, T.A., & Kashkalda, D.A. (2016). Thyroid dysfunction and secondary amenorrhea in girls. Sovremennaya pediatriya, 4(76), 113-116. https://doi.org/10.15574/SP.2016.76.113

Turchina, S.I., Nikitina, L.D., Levchuk, L.P., & Yudchenko, O.I. (2019). Physical development as an integral indicator of rehabilitation of patients with type 1 diabetes mellitus. Ukrainian Journal of Pediatric endocrinology, 2, 11-14. https://doi.org/10.30978/UJPE2019-2-11

Turchyna, S., Sotnikova-Meleshkina, Z., Kalmykova, Y., Kalmykov, S., & Mikhanovska, N. (2022a). The modern view on the correction of selenium deficiency from the position of evidence-based medicine. Problems of Endocrine Pathology, 79(4), 67-73. https://doi.org/10.21856/j-PEP.2022.4.09

Turchyna, S., Nikitina, L., Varodova, O., Kalmykova, Y., & Kalmykov, S. (2022b). Functional state of the GH/IGF-1 system in adolescents with type 1 diabetes mellitus. Physical rehabilitation and recreational health technologies, 7(4), 171-178. https://doi.org/10.15391/prrht.2022-7.171

Turchyna, S.I., Nikitina, L.D., Kostenko, T.P., Shliakhova, N.V., & Chumak, S.O. (2022c). Thyreopathy as an example of comorbid pathology in patients with type 1 diabetes mellitus. Innovative trends of science and practice, tasks and ways to solve them [Conference], Athens, Greece, 386-389. http://bit.ly/3jzohvf

Turchyna, S.I., Kosovtsov, G.V., Nikitina, L.D., Shushlyapina, O.V., & Varodova, O.V. (2022d). Type 1 diabetes mellitus and the developmental status of adolescent. Multidisciplinary academic notes. Theory, methodology and practice [conference], Tokyo, Japan, 513-518. http://bit.ly/3JD2Vun

Ventura, M., Melo, M., & Carrilho, F. (2017). Selenium and Thyroid Disease: From Pathophysiology to Treatment. Int. J. Endocrinol., 2017, 1297658. https://doi.org/10.1155/2017/1297658

Zimmermann, M.B. (2011). The role of iodine in human growth and development. Semin. Cell Dev. Biol., 22(6), 645-652. https://doi.org/10.1016/j.semcdb.2011.07.009

Downloads

Published

2023-03-31

Issue

Section

Original research article